Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease

Background: Alzheimer's disease (AD) is characterized by a neurodegenerative progression that alters cognition. On a phenotypical level, cognition is evaluated by means of the MiniMental State Examination (MMSE) and the post-morten examination of Neurofibrillary Tangle count (NFT) helps to conf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2010
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_19326203_v5_n4_p_GomezRavetti
http://hdl.handle.net/20.500.12110/paper_19326203_v5_n4_p_GomezRavetti
Aporte de:

Ejemplares similares